WMIC Jacob Javits Center at night

Jacob Javits Center in New York at night, the venue for the 2016 WMIC Annual Congress & Exhibition. Cubresa will display the NuPET™ MR-compatible PET scanner in booth 207.

Cubresa to Exhibit at the WMIC 2016 Annual Congress & Exhibition in New York

Cubresa WMIC iPad Pro winner

Cubresa Apple® iPad™ Pro winner, Dr. Patrick Chow, at WMIC booth 207. Left to Right: Michael Simpson, Director of Marketing, George Abe, CEO, and Dr. Patrick Chow, Principal Scientist, Preclinical Imaging at Bristol-Myers Squibb.

UPDATE: Congratulations to Patrick Chow of Bristol-Myers Squibb, on winning our custom-engraved Apple® iPad™ Pro in the booth on Saturday. Dr. Chow was selected at random from attendees who participated in our survey.

Bookmark this page1 because we will be adding more information up to and during the congress. Come visit us in Booth 207 at the Jacob Javits Convention Center in New York, September 7 to 10, 2016 where we will be showcasing our NuPET™ in-bore PET scanner for existing pre-clinical MRI systems.

The NuPET scanner enables simultaneous PET and MR imaging within your existing MRI system. Solid-state SiPM detectors optimized for in vivo PET imaging of small-animal subjects in the industry’s most compact form factor deliver high-performance without compromising your MRI’s capability. Get the quantitative data you’re looking for in applications such as:

  • Neurology
  • Oncology
  • Cardiology
  • Inflammation

Simultaneous PET/MRI mouse tumor image - BIOTIC MIP using NuPET™Simultaneous PET/MRI mouse tumor image - BIOTIC, Coronal using NuPET™Simultaneous PET/MRI mouse tumor image - BIOTIC, Sagittal using NuPET™Simultaneous PET/MRI mouse tumor image - BIOTIC, Axial using NuPET™







Above: C57BL/6 mouse bearing a C3 (cervical cancer) flank tumor injected with approximately 17.5 MBq of 18F-FDG. Left to Right: MIP, Coronal, Sagittal, and Axial views. Images courtesy BIOTIC.

U Arizona NuPET PET-DCE MR Image of A549 mouse tumor

A mixture of 18F-FDG PET agent and MultiHance® MRI agent was injected IV into a flank tumor model of human A549 lung cancer. The large tumor and a small portion of the mouse body are shown in this axial image orientation. Left: Average 18F-FDG PET signal overlaid on an anatomical MR image shows relative glucose uptake. Right: Dynamic Contrast Enhancement (DCE) MRI
was used to construct a map of relative vascular permeability. Images courtesy of University of Arizona.

Make an appointment to speak with us about your preclinical imaging needs. We believe that simultaneous PET/MRI imaging offers a unique opportunity for analyzing and understanding links between molecular mechanisms and functional phenomena within living organisms.